| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Dev. &Ops. Officer | Chief Development Officer
1 company
Shemesh Shay is a Chief Dev. &Ops. Officer at Nuvectis Pharma, Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $35.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Dev. &Ops. Officer | Buy | 1,278 | $15.85 | $20,254.66 | - | -53.2% | -10.5% | |
| Feb 7, 2022 | NVCT Nuvectis Pharma, Inc. | Chief Development Officer | Buy | 2,946 | $3.41 | $10,033.62 | +0.1% | +89.4% | +37.0% |